HSCT, to identify the risk factors related to potential infertility after HSCT and to provide data on longitudinal sperm recovery after HSCT.
Design and MethodsFor this retrospective multicenter study of the Late Effects Working Party of the EBMT all centers were asked if they had performed seminal analysis (SFA) in male patients before and after allogeneic HSCT, and if they would agree to provide information on all patients who had. Five hundred and forty-three centers were contacted of which 93 responded. Twenty-three Transplant Centers reported having data on SFA, and 19 of them finally contributed reports on a total of 259 patients; 224 of 259 were treated with allogeneic HSCT. Overall, 224 patients were included in this study.The EBMT is a voluntary group of transplant centers each of which is required to provide transplant-related information on each patient using a specific anonymous data collection form. Patients provide written informed consent to have their data on disease, treatment and outcome, including late complications, reported to the registry. Clinical surveillance of HSCT recipients was approved by the local institutional review boards. Patients' characteristics, HSCT conditioning regimens and clinical outcome data were collected prospectively and stored in the EBMT database.Details requested on seminal fluid parameters included the number and date of collections performed per patient, the sperm concentration, the motility and the morphology of the spermatozoa. Gonodotropic hormone and testosterone levels (if performed) were requested. Results of SFA were assessed according to the World Health Organization (WHO) guidelines. 15 Patients were considered to be normozoospermic when the sperm concentration exceeded 20x10 6 /mL, oligozoospermic when the sperm count was between 5 and 20x10 6 /mL, severely oligozoospermic with a sperm count below 5x10 6 /mL, and cryptospermic when spermatozoa were detected only after careful analysis of the concentrated sample. When no spermatozoa were detected patients were considered azoospermic.
Statistical analysisVariables significantly associated with the risk of infertility after allogeneic HSCT were assessed by univariate and multivariate analysis. Any presence of spermatozoa in SFA was considered as existence of spermatogenesis. Patients with sperm detectable in the SFA were compared to patients with no evidence of spermatogenesis, using the c 2 test for categorical data and the MannWhitney U test for continuous variables. Variables considered for infertility risk analysis were age at HSCT, disease, type of conditioning regimen (TBI≥7.5 Gray vs. busulfan containing regimen vs. regimen without TBI and without busulfan), occurrence of acute and chronic GVHD, persistence of chronic GVHD at time of SFA, continuous treatment with immunosuppression, and time interval between HSCT and SFA. For multivariate analysis, logistical regression with 2-sided significance levels was used to assess the impact of risk factors with infertility. A backward stepwise proc...